Tobacco Treatment Optimization and Preferences During Concurrent Cancer Treatment
Status:
Recruiting
Trial end date:
2023-03-30
Target enrollment:
Participant gender:
Summary
Smoking cessation has been shown to improve the effectiveness and reduce the morbidity of
tobacco-related cancer treatments. We will identify effective smoking cessation strategies
for patients who are receiving treatment for tobacco-related cancer. In this trial, patients'
preferences in smoking cessation therapy will be the principal determinant by providers in
developing a three component regimen of pharmaceutical therapy, counseling, and nicotine
replacement therapy. This study will identify this cohort's preferences for smoking cessation
strategies. We will then examine the impact of utilizing patient preferences upon cessation
efficacy by directly comparing cessation success in this study with our recently completed
study of the same population using the same tobacco treatments which were randomly assigned.